The finding that the cholesterol-mediated increase in the expression of these genes requires ERRα in both ER-positive and triple-negative breast cancer cells provides a mechanistic explanation for the adverse effect of high circulating cholesterol levels and may explain the beneficial effect of statins on breast cancer outcome. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.